Ro says annualized revenue grew over tenfold after revamp and GLP-1 weight-loss push
The telehealth company Ro said its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments, according to NYT DealBook. The post attributes the growth claim to the company and ties it to GLP-1 drugs and a business revamp.
Why “Unverified”
- Reported by NYT DealBook alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 68/100. How labels work
What the sources claim
-
Ro said its annualized revenue grew more than tenfold since it revamped its business and embraced weight-loss treatments.
“its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments”
NYT DealBook
Sources
More in Stocks & Indices
Embed this page
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-11 13:30 UTC. Labels are computed from the sources, not by the model.